CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Radicicol does not inhibit Elk phosphorylation. Cells were transiently transfected with Elk and subsequently treated for 36–40 h with radicicol or MEK inhibitors. Cell extracts were analyzed by Western blotting for phosphorylation status of Elk. Blots were first probed with anti-phospho-Elk (top panels) and subsequently stripped and reprobed with anti-Elk (bottom panels). A, ras-transformed NIH3T3 cells. B, MEK-1-S218D,S222D-infected NIH3T3 cells.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation